Bacterial Transcription as a Target for Antibacterial Drug Development

Microbiology and Molecular Biology Reviews : MMBR
Cong MaPeter J Lewis

Abstract

Transcription, the first step of gene expression, is carried out by the enzyme RNA polymerase (RNAP) and is regulated through interaction with a series of protein transcription factors. RNAP and its associated transcription factors are highly conserved across the bacterial domain and represent excellent targets for broad-spectrum antibacterial agent discovery. Despite the numerous antibiotics on the market, there are only two series currently approved that target transcription. The determination of the three-dimensional structures of RNAP and transcription complexes at high resolution over the last 15 years has led to renewed interest in targeting this essential process for antibiotic development by utilizing rational structure-based approaches. In this review, we describe the inhibition of the bacterial transcription process with respect to structural studies of RNAP, highlight recent progress toward the discovery of novel transcription inhibitors, and suggest additional potential antibacterial targets for rational drug design.

References

Apr 1, 1975·Antimicrobial Agents and Chemotherapy·G H WagmanM J Weinstein
Nov 1, 1992·Journal of Bacteriology·R A Salomón, R N Farías
Jan 1, 1990·The Journal of Antibiotics·G RömmeleW Wehrli
Feb 1, 1985·The Journal of Antibiotics·H IrschikH Reichenbach
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·P WiesnerM Turck
Oct 1, 1973·Journal of Bacteriology·D J Tipper
Sep 1, 1974·Journal of Bacteriology·G G Khachatourians, D J Tipper
Oct 1, 1972·The Journal of Antibiotics·T MiyoshiH Sakai
Jul 24, 1965·Nature·C CalvoriG Tecce
Jan 28, 1980·FEBS Letters·O N OzolineS G Kamzolova
Jul 1, 1983·Reviews of Infectious Diseases·P Sensi
Aug 1, 1995·The Journal of Antibiotics·H IrschikH Reichenbach
Sep 1, 1993·Microbiological Reviews·J Archambault, J D Friesen
Aug 1, 1997·Journal of Bacteriology·W L NowatzkeJ P Richardson
Apr 18, 1998·The Journal of Biological Chemistry·M V Sukhodolets, D J Jin
Mar 28, 1998·Antimicrobial Agents and Chemotherapy·L CarranoP Alifano
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·W B WhitmanW J Wiebe
Oct 22, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·A Eisen, J C Lucchesi
Mar 27, 1999·European Journal of Biochemistry·A BlondS Rebuffat
Apr 24, 1999·Science·W S Yarnell, J W Roberts
Jun 26, 1999·Molecular Microbiology·M Zellars, C L Squires
Jul 27, 1999·British Journal of Clinical Pharmacology·K F Barker
Jan 25, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S Ramaswamy, J M Musser
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·I Artsimovitch, R Landick
Aug 1, 2000·Science·N KorzhevaS A Darst

❮ Previous
Next ❯

Citations

Mar 23, 2017·ACS Chemical Biology·Scott S WalkerKatherine Young
Dec 15, 2016·Bioorganic & Medicinal Chemistry Letters·Peter J CossarAdam McCluskey
Sep 1, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Do-Hee KimBong-Jin Lee
Dec 1, 2017·Frontiers in Molecular Biosciences·Michael A ReicheValerie Mizrahi
Jul 14, 2018·Medicinal Research Reviews·Peter J CossarAdam McCluskey
Apr 19, 2017·PLoS Biology·Jorge Moura de SousaIsabel Gordo
Nov 28, 2018·Journal of Bacteriology·Tomáš KoubaLibor Krásný
Nov 23, 2018·Journal of Industrial Microbiology & Biotechnology·Sonia I MaffioliStefano Donadio
Sep 10, 2019·Nucleic Acids Research·Ranjit K PrajapatiGeorgiy A Belogurov
Jun 4, 2020·Chemical Biology & Drug Design·Mo-Han HuangXiang-Duan Tan
May 30, 2020·Journal of Medical Microbiology·Rudramani PokhrelJessica Siltberg-Liberles
Nov 21, 2019·Nature Reviews. Microbiology·Ursula TheuretzbacherAnders Karlén
Oct 31, 2019·Transcription·Markus C Wahl, Ranjan Sen
Aug 17, 2020·Nucleic Acids Research·Roman S Iwasaki, Robert T Batey
Nov 25, 2016·Frontiers in Molecular Biosciences·Jookyung Lee, Sergei Borukhov
Aug 17, 2020·International Journal of Molecular Sciences·Adrian Jun ChuXiao Yang
Feb 20, 2019·Physical Review. E·V Belitsky, G M Schütz
Oct 15, 2019·Frontiers in Genetics·Dixit SharmaShailender Kumar Verma
Jun 18, 2020·MBio·Mauricio H Pontes, Eduardo A Groisman
Oct 6, 2020·Frontiers in Bioengineering and Biotechnology·Gundeep KaurKrishan Gopal Thakur
Sep 9, 2020·Molecular Biology and Evolution·Jeremy R Dettman, Rees Kassen
Nov 30, 2018·Journal of Theoretical Biology·V Belitsky, G M Schütz
Feb 20, 2021·Proceedings of the National Academy of Sciences of the United States of America·Marie DelabyPatrick H Viollier
Feb 27, 2021·Journal of Theoretical Biology·G M Schütz
Apr 24, 2021·European Journal of Medicinal Chemistry·Kamal D PatelVijayalekshmi Sarojini
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mieke Hemiawati SatariDikdik Kurnia
May 25, 2021·Computational and Structural Biotechnology Journal·Pooja SinghSeyed E Hasnain
Aug 18, 2021·Transcription·Michael MillerPeter J Lewis
Aug 31, 2021·RSC Chemical Biology·Rashi KahanAnna Barnard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Protein Structures (ASM)

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Drug Discovery Today
Philippe Villain-GuillotJean-Paul Leonetti
The Journal of Antimicrobial Chemotherapy
Estelle AndréJean-Paul Leonetti
© 2022 Meta ULC. All rights reserved